| In recent years,China’s market environment has become more diversified due to the improvement of the level of economic development.At the same time,all walks of life are also facing increasing competitive pressure and development pressure.With the promotion of a new round of medical reform policy,the market environment of the pharmaceutical industry has undergone great changes.Especially in the current epidemic situation,many enterprises are likely to fall into financial crisis,and financial risk is the main source of this financial crisis.Therefore,how to strengthen the evaluation and control of enterprise financial risk has become one of the urgent problems to be solved in front of every enterprise manager.To prevent the occurrence of financial risks,the company must improve the management of financial risk awareness,and through the establishment of a set of effective risk evaluation mechanism,timely discovery of financial risks,in the first time to take scientific and effective preventive measures.This paper mainly studies the financial risk evaluation and control of L company as an example.Chinese medicines,Chinese herbal medicine in the pharmaceutical industry and processing industry listed companies in recent years,management present situation as well as the national policy changes,combined with the development of L company and annual changes of the financial indicators,it analyzes the cause of the risk and evaluate the reference evaluation standards of the state,selected the 66 listed pharmaceutical companies financial indicators data in 2020,SPSS software was used to conduct Pearson correlation analysis on various indicators,and 19 indicators were selected as financial risk evaluation indicators.Entropy method was used to determine the weight of each indicator,and a more scientific financial risk evaluation system was established.Then,combining with the current situation of L Company,the efficacy coefficient method is used to evaluate the basic situation of L company and its financial status in the past five years,and the comprehensive evaluation score of financial risk evaluation of L company from2016 to 2020 is calculated.Corresponding to the financial risk evaluation table,obtain the financial risk degree of L company in each year from 2016 to 2020.Through the financial risk evaluation,it is found that the investment capacity of the enterprise is lower than the average of the industry,the asset quality deteriorates seriously and the financing method is single and the debt pressure is big.The corresponding countermeasures are given to strengthen the R&D of differentiated products to seek new growth points,strengthen the management system of accounts receivable and inventory,broaden the financing channels to optimize the debt structure,train talents and implement the fine management of costs.I hope it can provide reference for L company in financial risk evaluation and control. |